Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
ABBVIE LIMITED,Adalimumab/etanercept,Rheumatoid arthritis - reduce number of prior DMARDs from 3 to 2,Adalimumab/etanercept (Humira),,Musculoskeletal System
